Circulation, Vol 59, 779-788, Copyright © 1979 by American Heart Association
D Wu, P Denes, R Bauernfeind, RC Dhingra, C Wyndham and KM Rosen
The electrophysiologic effects of atropine were studied in 14 patients with
dual atrioventricular (AV) nodal pathways and recurrent paroxysmal
supraventricular tachycardia (PSVT). During PSVT, all patients used a slow
pathway (SP) for antegrade and fast pathway (FP) for retrograde conduction.
Atropine enhanced both SP antegrade and FP retrograde conduction, shown by
a decrease in paced cycle lengths (atrial and ventricular) producing AV and
ventriculoatrial block. Five patients had induction of sustained PSVT
before and after atropine. Seven patients failed to induce or sustain PSVT
before atropine, because of retrograde FP refractoriness. All seven had
induction of sustained PSVT after atropine due to facilitation of FP
retrograde conduction. Two patients had only single atrial echoes before
atropine, reflecting SP antegrade refractoriness. After atropine, sustained
PSVT was inducible in one, and nonsustained in the other, PSVT cycle length
could be compared in seven patients before and after atropine and decreased
from 383 +/- 25 to 336 +/- 17 (p less than 0.05). Thus, in patients with
dual AV nodal pathways, atropine facilitated SP antegrade and FP retrograde
conduction, shortened cycle length of PSVT and potentiated ability to
sustain PSVT.
ARTICLES
Effects of atropine on induction and maintenance of atrioventricular nodal reentrant tachycardia
This article has been cited by other articles:
![]() |
H Hatzinikolaou, L-M Rodriguez, J L R M Smeets, C Timmermans, G Vrouchos, G Grecas, and H J J Wellens Isoprenaline and inducibility of atrioventricular nodal re-entrant tachycardia Heart, February 1, 1998; 79(2): 165 - 168. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1979 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |